Skip to main content

Peer Review reports

From: Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy

Original Submission
3 Jun 2022 Submitted Original manuscript
11 Aug 2022 Reviewed Reviewer Report
15 Aug 2022 Reviewed Reviewer Report
7 Sep 2022 Author responded Author comments - Yuanxi Huang
Resubmission - Version 2
7 Sep 2022 Submitted Manuscript version 2
15 Sep 2022 Author responded Author comments - Yuanxi Huang
Resubmission - Version 3
15 Sep 2022 Submitted Manuscript version 3
29 Sep 2022 Reviewed Reviewer Report
10 Oct 2022 Author responded Author comments - Yuanxi Huang
Resubmission - Version 4
10 Oct 2022 Submitted Manuscript version 4
14 Oct 2022 Author responded Author comments - Yuanxi Huang
Resubmission - Version 5
14 Oct 2022 Submitted Manuscript version 5
19 Oct 2022 Author responded Author comments - Yuanxi Huang
Resubmission - Version 6
19 Oct 2022 Submitted Manuscript version 6
6 Nov 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
7 Nov 2022 Editorially accepted
2 Dec 2022 Article published 10.1186/s12885-022-10291-2

You can find further information about peer review here.

Back to article page